mRNA vaccines and SiRNAs targeting cancer immunotherapy: challenges and opportunities.

Discov Oncol · 2025 · PMC12227412 · PMID 40615758

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Tumor cells must be capable of adapting to shifting microenvironments, such as stress or chemotherapy medications, to continue to survive, suggesting that RNA alterations may be significant in cancer [ 66 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.